Targeted Molecular Investigation in Patients within the Clinical Spectrum of Auriculocondylar Syndrome
Carregando...
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
TAVARES, Vanessa L. Romanelli
ZECHI-CEIDE, Roseli M.
GORDON, Christopher T.
FERREIRA, Simone G.
HSIA, Gabriella S. P.
EZQUINA, Suzana A. M.
KOKITSU-NAKATA, Nancy M.
VENDRAMINI-PITTOLI, Siulan
Citação
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, v.173, n.4, p.938-945, 2017
Resumo
Auriculocondylar syndrome, mainly characterized by micrognathia, small mandibular condyle, and question mark ears, is a rare disease segregating in an autosomal dominant pattern in the majority of the families reported in the literature. So far, pathogenic variants in PLCB4, GNAI3, and EDN1 have been associated with this syndrome. It is caused by a developmental abnormality of the first and second pharyngeal arches and it is associated with great inter- and intra-familial clinical variability, with some patients not presenting the typical phenotype of the syndrome. Moreover, only a few patients of each molecular subtype of Auriculocondylar syndrome have been reported and sequenced. Therefore, the spectrum of clinical and genetic variability is still not defined. In order to address these questions, we searched for alterations in PLCB4, GNAI3, and EDN1 in patients with typical Auriculocondylar syndrome (n - 3), Pierre Robin sequence-plus (n - 3), micrognathia with additional craniofacial malformations (n - 4), or non-specific auricular dysplasia (n - 1), which could represent subtypes of Auriculocondylar syndrome. We found novel pathogenic variants in PLCB4 only in two of three index patients with typical Auriculocondylar syndrome. We also performed a detailed comparative analysis of the patients presented in this study with those previously published, which showed that the pattern of auricular abnormality and full cheeks were associated with molecularly characterized individuals with Auriculocondylar syndrome. Finally, our data contribute to a better definition of a set of parameters for clinical classification that may be used as a guidance for geneticists ordering molecular testing for Auriculocondylar syndrome. (C) 2017 Wiley Periodicals, Inc.
Palavras-chave
Auriculocondylar syndrome, PLCB4, pharyngeal arch, clinical heterogeneity, Pierre Robin sequence, micrognathia, ear dysplasia, question mark ear
Referências
- Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
- Allanson JE, 2009, AM J MED GENET A, V149A, P6, DOI 10.1002/ajmg.a.32612
- Carey JC, 2012, HUM MUTAT, V33, P781, DOI 10.1002/humu.22053
- Clouthier DE, 2013, AM J MED GENET C, V163, P306, DOI 10.1002/ajmg.c.31376
- ELLIS MV, 1995, BIOCHEM J, V307, P69
- Gordon CT, 2013, AM J HUM GENET, V93, P1118, DOI 10.1016/j.ajhg.2013.10.023
- Gordon CT, 2013, J MED GENET, V50, P174, DOI 10.1136/jmedgenet-2012-101331
- Guion-Almeida ML, 2002, AM J MED GENET, V112, P209, DOI 10.1002/ajmg.10631
- Johnson JM, 2011, AM J NEURORADIOL, V32, P230, DOI 10.3174/ajnr.A2073
- Kido Y, 2013, AM J MED GENET A, V161, P2339, DOI 10.1002/ajmg.a.36066
- Kokitsu-Nakata NM, 2012, AM J MED GENET A, V158A, P59, DOI 10.1002/ajmg.a.34337
- Lajeunie E, 2006, EUR J HUM GENET, V14, P289, DOI 10.1038/sj.ejhg.5201558
- Leoni C, 2016, AM J MED GENET A, V170, P1471, DOI 10.1002/ajmg.a.37625
- Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
- Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243
- Marivin A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad2429
- Masotti C, 2008, EUR J HUM GENET, V16, P145, DOI 10.1038/sj.ejhg.5201955
- McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
- MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
- Nagano K, 1999, J BIOL CHEM, V274, P2872, DOI 10.1074/jbc.274.5.2872
- Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
- Passos-Bueno MR, 2009, AM J MED GENET A, V149A, P1853, DOI 10.1002/ajmg.a.32950
- Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281
- Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
- Rieder MJ, 2012, AM J HUM GENET, V90, P907, DOI 10.1016/j.ajhg.2012.04.002
- Tavares VLR, 2015, EUR J HUM GENET, V23, P481, DOI 10.1038/ejhg.2014.132
- Shkalim V, 2008, AM J MED GENET A, V146A, P2280, DOI 10.1002/ajmg.a.32452
- Suh PG, 2008, BMB REP, V41, P415
- Tan TY, 2013, AM J MED GENET C, V163, P295, DOI 10.1002/ajmg.c.31374
- Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
- Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438
- Walker MB, 2007, DEV BIOL, V304, P194, DOI 10.1016/j.ydbio.2006.12.027
- Wang K, 2010, NUCLEIC ACIDS RES, V38, pe164, DOI 10.1093/NAR/GKQ603